Description

ENROSTRONG 10% VET SOLU. 100ML

Indications

ENROSTRONG 10% VET SOLU. is an antimicrobial veterinary medication primarily indicated for the treatment of bacterial infections in animals. It is particularly effective against a variety of Gram-negative and some Gram-positive bacteria. Common indications include respiratory tract infections, urinary tract infections, and skin infections in dogs and cats. The solution is also used as a therapeutic agent in cases of enteritis and other gastrointestinal infections caused by susceptible bacteria.

Mechanism of Action

ENROSTRONG contains enrofloxacin, a fluoroquinolone antibiotic that exerts its antimicrobial effect by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are crucial for bacterial DNA replication, transcription, and repair. By interfering with these processes, enrofloxacin effectively halts bacterial growth and replication, leading to the elimination of the infection. The concentration-dependent bactericidal activity of enrofloxacin allows for effective treatment even at lower doses, reducing the risk of adverse effects.

Pharmacological Properties

ENROSTRONG is rapidly absorbed following oral administration, with peak plasma concentrations occurring within one to two hours. The bioavailability of enrofloxacin is high, allowing for effective dosing in various animal species. The drug is widely distributed in body tissues and fluids, including the lungs, liver, kidneys, and prostate. It is primarily metabolized in the liver to its active metabolite, ciprofloxacin, and excreted via urine and feces. The elimination half-life in dogs is approximately 2 to 5 hours, while in cats, it ranges from 3 to 6 hours, necessitating careful consideration of dosing intervals.

Contraindications

ENROSTRONG should not be administered to animals with known hypersensitivity to enrofloxacin or other fluoroquinolones. It is contraindicated in growing animals due to the potential for cartilage damage and joint issues. Additionally, the use of ENROSTRONG is not recommended in pregnant or lactating animals unless the benefits outweigh the risks. Animals with pre-existing central nervous system disorders should also avoid this medication due to the potential for exacerbation of these conditions.

Side Effects

While ENROSTRONG is generally well-tolerated, some animals may experience side effects. Common side effects include gastrointestinal disturbances such as vomiting, diarrhea, and loss of appetite. Neurological effects, including seizures and ataxia, have been reported, particularly in cases of overdose or in sensitive individuals. Rarely, allergic reactions may occur, presenting as swelling, hives, or difficulty breathing. If any adverse reactions are observed, it is crucial to discontinue the medication and seek veterinary assistance immediately.

Dosage and Administration

The recommended dosage of ENROSTRONG varies based on the type and severity of the infection, as well as the species and weight of the animal. For dogs, the typical dosage ranges from 5 to 20 mg/kg body weight, administered once daily. For cats, the dosage is usually between 5 to 10 mg/kg body weight, also given once daily. It is essential to follow the veterinarian’s instructions regarding dosage and duration of treatment, typically ranging from 5 to 14 days depending on the clinical response. ENROSTRONG can be administered orally, and it is advisable to give the medication with food to enhance absorption and reduce gastrointestinal side effects.

Interactions

ENROSTRONG may interact with other medications, which can affect its efficacy or increase the risk of adverse effects. Antacids, sucralfate, and other products containing magnesium, aluminum, or calcium can reduce the absorption of enrofloxacin, leading to decreased effectiveness. Concurrent use with non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of central nervous system toxicity. It is essential to inform the veterinarian of all medications and supplements the animal is currently taking to avoid potential interactions.

Precautions

Before administering ENROSTRONG, a thorough veterinary assessment is recommended to evaluate the animal’s health status and medical history. Special caution should be exercised in animals with renal impairment, as dosage adjustments may be necessary to prevent accumulation and toxicity. It is also essential to monitor for any signs of adverse reactions, particularly during the initial stages of treatment. Regular follow-up appointments with the veterinarian are advised to assess the effectiveness of the treatment and make any necessary adjustments.

Clinical Studies

Clinical studies have demonstrated the efficacy of enrofloxacin in treating various bacterial infections in dogs and cats. In a study published in the Journal of Veterinary Internal Medicine, enrofloxacin was shown to be effective in treating complicated urinary tract infections in dogs, with a success rate of over 80%. Another study highlighted its effectiveness in treating respiratory infections in cats, with significant improvement noted within a few days of treatment. These studies underscore the importance of enrofloxacin as a valuable therapeutic option in veterinary medicine.

Conclusion

ENROSTRONG 10% VET SOLU. is a potent antimicrobial solution that plays a crucial role in the treatment of bacterial infections in dogs and cats. With its well-established mechanism of action, pharmacological properties, and clinical efficacy, it is a valuable tool in veterinary practice. However, responsible use, adherence to dosing guidelines, and awareness of potential side effects and interactions are essential for ensuring the safety and well-being of treated animals. Always consult with a veterinarian before starting any new medication to ensure it is appropriate for the specific needs of your pet.